Posttranslational modifications of defined embryonic reprogramming transcription factors

Area of Science:

• Stem cell biology
• Molecular oncology
• Epigenetics

Background:

• Induced pluripotent stem cells (iPSCs) are generated from somatic cells using reprogramming factors.
• iPSC technology faces safety concerns, primarily tumorigenesis, hindering therapeutic applications.
• Novel methods like chemical induction or direct factor delivery offer promising avenues for cell therapy.

Purpose of the Study:

• To review the role of posttranslational modifications (PTMs) in regulating the biological functions of key reprogramming factors (Oct3/4, Sox2, Klf4, c-Myc, Nanog).
• To explore the application of PTM knowledge in developing safer and more efficient iPSC generation methods for cell therapy.
• To discuss the implications of PTMs of reprogramming factors in tumor pathogenesis.

Main Methods:

• Literature review and synthesis of existing evidence on PTMs of reprogramming factors.
• Analysis of the impact of various PTMs (phosphorylation, ubiquitination, acetylation, sumoylation) on protein function.
• Examination of the link between PTMs and cellular processes including proliferation, differentiation, and apoptosis.

Main Results:

• PTMs critically control the activity, expression, and stability of reprogramming factors.
• Specific PTMs influence diverse cellular functions, including those relevant to tumorigenesis.
• Understanding these modifications is key to mitigating iPSC-related safety risks.

Conclusions:

• PTMs are essential regulators of reprogramming factor function and are vital for safe and effective cell therapy.
• Targeting PTMs offers a strategy to develop cancer-free reprogramming protocols.
• Further research into PTMs will advance both regenerative medicine and cancer research.